The Effectiveness of Nanomedicine in Relation to Traditional Therapies for Breast Carcinoma Treatment: Current Possibilities and Future Outlook

Introduction: Breast cancer is one of the most prevalent cancers among women worldwide. In recent years, a significant proportion of breast cancer research in Pakistan, accounting for nearly two-thirds, has focused on this disease. Nanotechnology has emerged as a promising tool in the detection, diagnosis, and treatment of breast cancer. This study presents an analysis of traditional breast cancer therapies and compares them with recent developments in nanomedicine. Methods: The data were collected from online databases, including Google Scholar, PubMed, and Web of Science, to support the current study. Results: Various treatments face challenges, including complications and drug resistance. A new approach has been developed to overcome chemoresistance in breast cancer patients. Nanotechnology utilizes both organic and inorganic methods to address breast cancer, aiming to reduce tumor size and impede its development. The nanomedicine treatment involves active, passive, and stimuli-responsive targeting of nanocarriers to tumor cells. Although nanomedicine shows high effectiveness, careful consideration must be given to the potential toxicity of nanomaterials, particularly their impact on the immune system. Discussion: Nanomedicine offers a promising solution to overcome chemoresistance in breast cancer by targeted drug delivery through nanocarriers. While effective in reducing tumors, concerns about nanomaterial toxicity, especially its impact on the immune system, must be addressed. Conclusion: In summary, nanomedicine proves to be an efficient method for treating breast cancer tumor growth. Further work is necessary to design safer and more effective medicines through nanomedicine.